why is compounded tirzepatide still being sold FDA Allows Compounded Tirzepatide During

Always consult a doctor to confirm whether this medication is suitable

It also requires a long-term commitment, as weight regain is common if treatment is stopped

In plain English, it slows how quickly food leaves the stomach, reduces appetite by signaling fullness to the brain, and stimulates insulin release but only when blood sugar is elevated

Doctors warn that complications can be worse if the drugs are misused, for example, taken to lose a few pounds or bought from unregulated online sellers

Clinical observations suggest: Some patients report heartburn or acid regurgitation symptoms after starting tirzepatide Individuals with pre-existing reflux symptoms may experience exacerbation Symptoms appear more common during initial treatment phases and dose escalation Symptoms may correlate with larger meal sizes or lying down shortly after eating The exact frequency of reflux symptoms varies by indication, dose, and individual patient factors